HUT41387A - Process for preparing new piperidine derivatives - Google Patents

Process for preparing new piperidine derivatives

Info

Publication number
HUT41387A
HUT41387A HU862738A HU273886A HUT41387A HU T41387 A HUT41387 A HU T41387A HU 862738 A HU862738 A HU 862738A HU 273886 A HU273886 A HU 273886A HU T41387 A HUT41387 A HU T41387A
Authority
HU
Hungary
Prior art keywords
piperidine derivatives
preparing new
new piperidine
preparing
derivatives
Prior art date
Application number
HU862738A
Other languages
English (en)
Other versions
HU196058B (en
Inventor
Albert A Carr
Norbert L Wiech
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of HUT41387A publication Critical patent/HUT41387A/hu
Publication of HU196058B publication Critical patent/HU196058B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU862738A 1985-07-02 1986-07-01 Process for producing new piperidine-methanol derivatives HU196058B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75141985A 1985-07-02 1985-07-02

Publications (2)

Publication Number Publication Date
HUT41387A true HUT41387A (en) 1987-04-28
HU196058B HU196058B (en) 1988-09-28

Family

ID=25021900

Family Applications (1)

Application Number Title Priority Date Filing Date
HU862738A HU196058B (en) 1985-07-02 1986-07-01 Process for producing new piperidine-methanol derivatives

Country Status (21)

Country Link
EP (1) EP0208235B1 (hu)
JP (1) JPH0655720B2 (hu)
KR (1) KR900001184B1 (hu)
CN (1) CN1023895C (hu)
AR (2) AR241904A1 (hu)
AT (1) ATE49403T1 (hu)
AU (1) AU590582B2 (hu)
CA (1) CA1280421C (hu)
DE (1) DE3668167D1 (hu)
DK (1) DK174153B1 (hu)
ES (1) ES2000299A6 (hu)
FI (1) FI84474C (hu)
GR (1) GR861699B (hu)
HU (1) HU196058B (hu)
IE (1) IE58460B1 (hu)
IL (1) IL79266A (hu)
NO (1) NO167384C (hu)
NZ (1) NZ216689A (hu)
PH (1) PH22141A (hu)
PT (1) PT82890B (hu)
ZA (1) ZA864772B (hu)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR910006138B1 (ko) * 1986-09-30 1991-08-16 에자이 가부시끼가이샤 환상아민 유도체
ZA888572B (en) * 1987-11-23 1989-08-30 Merrell Dow Pharma Treatment of fibromyalgia
JPH02138214A (ja) * 1987-12-10 1990-05-28 Merrell Dow Pharmaceut Inc 不安を治療する方法
US5093341A (en) * 1987-12-17 1992-03-03 Merrell Dow Pharmaceuticals Inc. N-aralkyl piperidine derivatives useful as antithrombolytic agents
DE3888340T2 (de) * 1988-01-21 1994-06-30 Merrell Dow Pharma Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
ZA891901B (en) * 1988-03-17 1989-11-29 Merrell Dow Pharma Method for the treatment of the extrapyramidal side effects associated with neuroleptic therapy
JP2969359B2 (ja) * 1989-01-13 1999-11-02 武田薬品工業株式会社 環状アミン化合物
US5032598A (en) * 1989-12-08 1991-07-16 Merck & Co., Inc. Nitrogens containing heterocyclic compounds as class III antiarrhythmic agents
AU636421B2 (en) * 1989-12-20 1993-04-29 Merrell Dow Pharmaceuticals Inc. Method for the treatment of glaucoma
JP2758050B2 (ja) * 1989-12-27 1998-05-25 株式会社トクヤマ 土質安定用薬液およびその注入工法
US6004980A (en) * 1990-06-01 1999-12-21 Merrell Pharmaceuticals, Inc. (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
CA2083698C (en) * 1990-06-01 1997-11-04 Albert A. Carr (+)-alpha-(2,3-dimethoxyphenyl)-1- [2-(4-fluorophenyl) ethyl]-4-piperidinemethanol
JPH07111050B2 (ja) * 1990-12-12 1995-11-29 株式会社親和テクノ セメントグラウトを用いた地盤注入工法
FR2672286B1 (fr) * 1991-01-31 1994-11-18 Synthelabo Derives de 1-(4-chlorophenyl)-2-[4-(phenylmethyl)piperidin-1-yl]ethanol, leur preparation et leur application en therapeutique.
ZA929008B (en) * 1991-12-13 1993-05-21 Bristol Myers Squibb Co Piperazinyl- and piperidinyl-cyclohexanols.
WO1994000432A1 (en) * 1992-06-30 1994-01-06 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Anorectic epinephrine derivatives
FR2696741B1 (fr) * 1992-10-12 1994-11-25 Synthelabo Dérivés de 1-(4-chlorophényl)-2-[4-[(4-fluorophényl)méthyl]piperidin-1-yl] éthanol, leur préparation et leur application en thérapeutique.
CA2108245A1 (en) * 1992-11-04 1994-05-05 Gary J. Grover Method for treating myocardial ischemia employing serotonin receptor antagonists
EP0661266A1 (en) * 1993-12-27 1995-07-05 Toa Eiyo Ltd. Substituted cyclic amine compounds as 5HT2 antagonists
WO1997022583A1 (de) * 1995-12-20 1997-06-26 Eckhart Pein Neue 1-phenylalkyl/alkylen-4-(.alpha.-hydroxydiphenylmethyl)-piperidin derivate und ihre verwendung als serotonin antagonisten
US6028083A (en) * 1997-07-25 2000-02-22 Hoechst Marion Roussel, Inc. Esters of (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol
US6713627B2 (en) 1998-03-13 2004-03-30 Aventis Pharmaceuticals Inc. Processes for the preparation of (R)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
TWI249526B (en) * 1998-03-13 2006-02-21 Aventis Pharma Inc Novel processes for the preparation of (R)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
SE9801516D0 (sv) * 1998-04-30 1998-04-30 Maria Carlsson M100907/4-Piperidinemethanol derivatives for autism
DE19934432A1 (de) 1999-07-22 2001-02-01 Merck Patent Gmbh Indolderivate
DE19939756A1 (de) * 1999-08-21 2001-02-22 Merck Patent Gmbh Piperidinalkohole
US7345096B2 (en) 2002-10-15 2008-03-18 Wyeth Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms
US7531543B2 (en) 2003-10-14 2009-05-12 Wyeth Phenylpiperazine cycloalkanol derivatives and methods of their use
US7491723B2 (en) 2003-10-14 2009-02-17 Wyeth Alkanol and cycloalkanol-amine derivatives and methods of their use
US7524846B2 (en) 2003-10-14 2009-04-28 Wyeth Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use
US7402698B2 (en) 2003-10-14 2008-07-22 Wyeth Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use
US7550485B2 (en) 2003-10-14 2009-06-23 Wyeth Substituted N-heterocycle derivatives and methods of their use
US7419980B2 (en) 2003-10-14 2008-09-02 Wyeth Fused-aryl and heteroaryl derivatives and methods of their use
US7365076B2 (en) 2003-10-14 2008-04-29 Wyeth Substituted aryl cycloalkanol derivatives and methods of their use
PL1691811T3 (pl) 2003-12-11 2014-12-31 Sunovion Pharmaceuticals Inc Skojarzenie leku uspokajającego i modulatora neuroprzekaźnikowego oraz sposoby poprawy jakości snu i leczenia depresji
DE102004010132A1 (de) 2004-02-27 2005-09-15 Merck Patent Gmbh Piperidinderivate
US7414052B2 (en) 2004-03-30 2008-08-19 Wyeth Phenylaminopropanol derivatives and methods of their use
US7517899B2 (en) 2004-03-30 2009-04-14 Wyeth Phenylaminopropanol derivatives and methods of their use
WO2006029182A2 (en) * 2004-09-07 2006-03-16 The La Jolla Institute For Molecular Medicine Use of mdl-100,907 for treatment of allergic and eosinophil mediated diseases
CN118344282A (zh) * 2024-04-12 2024-07-16 中国人民解放军海军军医大学 一种艾芬地尔衍生物及其制备方法与应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3100775A (en) * 1959-04-01 1963-08-13 Searle & Co alpha-phenyl(pyridyl or piperidyl)alkyl esters of (chloro or lower alkoxy)-benzoic acids and congeners
ZA717147B (en) * 1970-11-27 1972-07-26 Richardson Merrell Inc 4-(4-(alpha-hydroxybenzyl)piperidino)-4'-fluorobutyrophenone derivatives
SE7409245L (hu) * 1973-07-19 1975-01-20 Robins Co Inc A H
FR2534580A1 (fr) * 1982-10-13 1984-04-20 Synthelabo Derives de phenyl-1 piperidino-2 propanol, leur preparation, et medicaments qui les contiennent
KR910006138B1 (ko) * 1986-09-30 1991-08-16 에자이 가부시끼가이샤 환상아민 유도체

Also Published As

Publication number Publication date
NZ216689A (en) 1989-07-27
DE3668167D1 (de) 1990-02-15
ZA864772B (en) 1987-02-25
CN86104408A (zh) 1987-05-20
NO167384C (no) 1991-10-30
PT82890B (pt) 1988-05-27
AR242184A1 (es) 1993-03-31
IE861771L (en) 1987-01-02
ATE49403T1 (de) 1990-01-15
AU5931886A (en) 1987-01-08
GR861699B (en) 1986-10-31
FI84474B (fi) 1991-08-30
NO167384B (no) 1991-07-22
NO862661D0 (no) 1986-07-01
AR241904A1 (es) 1993-01-29
FI862801L (fi) 1987-01-03
KR900001184B1 (ko) 1990-02-27
EP0208235B1 (en) 1990-01-10
IL79266A (en) 1990-04-29
EP0208235A1 (en) 1987-01-14
PT82890A (en) 1986-08-01
JPH0655720B2 (ja) 1994-07-27
CN1023895C (zh) 1994-03-02
CA1280421C (en) 1991-02-19
NO862661L (no) 1987-01-05
AU590582B2 (en) 1989-11-09
IE58460B1 (en) 1993-09-22
ES2000299A6 (es) 1988-02-16
HU196058B (en) 1988-09-28
JPS625955A (ja) 1987-01-12
FI84474C (fi) 1991-12-10
DK312386D0 (da) 1986-07-01
DK312386A (da) 1987-01-03
FI862801A0 (fi) 1986-07-01
DK174153B1 (da) 2002-07-29
PH22141A (en) 1988-06-01
KR870001164A (ko) 1987-03-11

Similar Documents

Publication Publication Date Title
HUT41387A (en) Process for preparing new piperidine derivatives
YU116787A (en) Process for obtaining imidazochynolinic derivatives
HUT40431A (en) Process for preparing piperidine derivatives
HUT40454A (en) Process for preparing 4-substituted androstene-dione derivatives
YU183586A (en) Process for obtaining chynoline derivatives
PT85628A (en) Process for preparing piperidine derivatives
HUT44530A (en) Process for producing furanon derivatives
PT86427A (en) Process for preparing piperidine derivatives
PT83820A (en) Process for preparing thioxanthone derivatives
HUT41768A (en) Process for producing diphenyl-piperidine derivatives
HUT42441A (en) Process for preparing indolyl- and indazolyl-carboxamide derivatives
EP0199997A3 (en) Process for preparing diaryl-pentaerythritol
YU210187A (en) Process for obtaining imidazolylalkylguanidinic derivatives
HUT42500A (en) New process for preparing sphyngosine derivatives
HUT42502A (en) Process for preparing new erythromycine derivatives
HUT40416A (en) Process for preparing dihydro-pyridine derivatives
HUT44501A (en) Process for producing dihydr-pyridine derivatives
HUT37755A (en) Process for preparing dihydropyridine derivatives
HUT42755A (en) Process for preparing azetidine derivatives
HUT43617A (en) Process for producing gonatriene derivatives
PT81988A (en) Process for preparing novel alkylamino-furanone derivatives
HUT40412A (en) Process for preparing dihydropyridine derivatives
HUT42432A (en) Process for preparing substituted phenyl-carbamide derivatives
HUT40415A (en) Process for producing dihydropyridine derivatives
PT82643A (en) Process for preparing substituted hexanydro arylquinolizines

Legal Events

Date Code Title Description
HU90 Patent valid on 900628